178 related articles for article (PubMed ID: 2556314)
1. Cytotoxic activities of a fusion protein comprised of TGF alpha and Pseudomonas exotoxin.
Siegall CB; Xu YH; Chaudhary VK; Adhya S; Fitzgerald D; Pastan I
FASEB J; 1989 Dec; 3(14):2647-52. PubMed ID: 2556314
[TBL] [Abstract][Full Text] [Related]
2. Transforming growth factor alpha-Pseudomonas exotoxin fusion protein prolongs survival of nude mice bearing tumor xenografts.
Heimbrook DC; Stirdivant SM; Ahern JD; Balishin NL; Patrick DR; Edwards GM; Defeo-Jones D; FitzGerald DJ; Pastan I; Oliff A
Proc Natl Acad Sci U S A; 1990 Jun; 87(12):4697-701. PubMed ID: 2352944
[TBL] [Abstract][Full Text] [Related]
3. Heparin-binding transforming growth factor alpha-Pseudomonas exotoxin A. A heparan sulfate-modulated recombinant toxin cytotoxic to cancer cells and proliferating smooth muscle cells.
Mesri EA; Kreitman RJ; Fu YM; Epstein SE; Pastan I
J Biol Chem; 1993 Mar; 268(7):4853-62. PubMed ID: 8444864
[TBL] [Abstract][Full Text] [Related]
4. Analysis of sequences required for the cytotoxic action of a chimeric toxin composed of Pseudomonas exotoxin and transforming growth factor alpha.
Kihara A; Pastan I
Bioconjug Chem; 1994; 5(6):532-8. PubMed ID: 7873657
[TBL] [Abstract][Full Text] [Related]
5. Epidermal growth factor receptor binding is affected by structural determinants in the toxin domain of transforming growth factor-alpha-Pseudomonas exotoxin fusion proteins.
Edwards GM; DeFeo-Jones D; Tai JY; Vuocolo GA; Patrick DR; Heimbrook DC; Oliff A
Mol Cell Biol; 1989 Jul; 9(7):2860-7. PubMed ID: 2779550
[TBL] [Abstract][Full Text] [Related]
6. Cytotoxicity and antitumor effects of growth factor-toxin fusion proteins on human glioblastoma multiforme cells.
Kunwar S; Pai LH; Pastan I
J Neurosurg; 1993 Oct; 79(4):569-76. PubMed ID: 7692018
[TBL] [Abstract][Full Text] [Related]
7. TGF alpha-anti-Tac(Fv)-PE40: a bifunctional toxin cytotoxic for cells with EGF or IL2 receptors.
Batra JK; Chaudhary VK; FitzGerald D; Pastan I
Biochem Biophys Res Commun; 1990 Aug; 171(1):1-6. PubMed ID: 2393383
[TBL] [Abstract][Full Text] [Related]
8. Cytotoxic effect of a fusion protein from transforming growth factor alpha and Pseudomonas exotoxin on rat and human bladder carcinoma cells in vitro.
Kameyama S; Kawamata H; Pastan I; Oyasu R
J Cancer Res Clin Oncol; 1994; 120(9):507-12. PubMed ID: 8045915
[TBL] [Abstract][Full Text] [Related]
9. Cytotoxic effects of a recombinant chimeric toxin on rapidly proliferating vascular smooth muscle cells.
Epstein SE; Siegall CB; Biro S; Fu YM; FitzGerald D; Pastan I
Circulation; 1991 Aug; 84(2):778-87. PubMed ID: 1860221
[TBL] [Abstract][Full Text] [Related]
10. A recombinant form of Pseudomonas exotoxin directed at the epidermal growth factor receptor that is cytotoxic without requiring proteolytic processing.
Theuer CP; FitzGerald D; Pastan I
J Biol Chem; 1992 Aug; 267(24):16872-7. PubMed ID: 1512230
[TBL] [Abstract][Full Text] [Related]
11. Biological activity of a transforming growth factor-alpha--Pseudomonas exotoxin fusion protein in vitro and in vivo.
Heimbrook DC; Stirdivant SM; Ahern JD; Balishin NL; Patrick DR; Edwards GM; Defeo-Jones D; FitzGerald DJ; Pastan I; Oliff A
J Ind Microbiol; 1991 Apr; 7(3):203-7. PubMed ID: 1367127
[TBL] [Abstract][Full Text] [Related]
12. Functional analysis of domains II, Ib, and III of Pseudomonas exotoxin.
Siegall CB; Chaudhary VK; FitzGerald DJ; Pastan I
J Biol Chem; 1989 Aug; 264(24):14256-61. PubMed ID: 2503515
[TBL] [Abstract][Full Text] [Related]
13. Activity of a recombinant fusion protein between transforming growth factor type alpha and Pseudomonas toxin.
Chaudhary VK; FitzGerald DJ; Adhya S; Pastan I
Proc Natl Acad Sci U S A; 1987 Jul; 84(13):4538-42. PubMed ID: 3299371
[TBL] [Abstract][Full Text] [Related]
14. Basic fibroblast growth factor-Pseudomonas exotoxin chimeric proteins; comparison with acidic fibroblast growth factor-Pseudomonas exotoxin.
Gawlak SL; Pastan I; Siegall CB
Bioconjug Chem; 1993; 4(6):483-9. PubMed ID: 7508267
[TBL] [Abstract][Full Text] [Related]
15. Cytotoxic activity of a recombinant fusion protein between interleukin 4 and Pseudomonas exotoxin.
Ogata M; Chaudhary VK; FitzGerald DJ; Pastan I
Proc Natl Acad Sci U S A; 1989 Jun; 86(11):4215-9. PubMed ID: 2657746
[TBL] [Abstract][Full Text] [Related]
16. A target-specific chimeric toxin composed of epidermal growth factor and Pseudomonas exotoxin A with a deletion in its toxin-binding domain.
Liao CW; Hseu TH; Hwang J
Appl Microbiol Biotechnol; 1995 Jul; 43(3):498-507. PubMed ID: 7632400
[TBL] [Abstract][Full Text] [Related]
17. Antitumor activity of a transforming growth factor alpha-Pseudomonas exotoxin fusion protein (TGF-alpha-PE40).
Pai LH; Gallo MG; FitzGerald DJ; Pastan I
Cancer Res; 1991 Jun; 51(11):2808-12. PubMed ID: 2032221
[TBL] [Abstract][Full Text] [Related]
18. Pseudomonas exotoxin A-epidermal growth factor (EGF) mutant chimeric protein as an indicator for identifying amino acid residues important in EGF-receptor interaction.
Shiah HS; Chen TY; Chang CM; Chow JT; Kung HJ; Hwang J
J Biol Chem; 1992 Nov; 267(33):24034-40. PubMed ID: 1429738
[TBL] [Abstract][Full Text] [Related]
19. Substitution of foreign protein sequences into a chimeric toxin composed of transforming growth factor alpha and Pseudomonas exotoxin.
Debinski W; Siegall CB; Fitzgerald D; Pastan I
Mol Cell Biol; 1991 Mar; 11(3):1751-3. PubMed ID: 1671711
[TBL] [Abstract][Full Text] [Related]
20. An EGF-pseudomonas exotoxin A recombinant protein with a deletion in toxin binding domain specifically kills EGF receptor bearing cells.
Lee CH; Lee EC; Tsai ST; Kung HJ; Liu YC; Hwang J
Protein Eng; 1993 Jun; 6(4):433-40. PubMed ID: 8332601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
